<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>PR.com Press Releases: NanoCellect News</title>
		<link>https://www.PR.com/</link>
		<description>Latest news releases from PR.com for NanoCellect.</description>
		<lastBuildDate>Fri, 06 Mar 2026 19:15:22 -0500</lastBuildDate>
		<copyright>&#169; 2026 PR.com</copyright>
		<ttl>60</ttl>
		<language>en-us</language>
		<image>
			<url>https://www.PR.com/images/logo_white.jpg</url>
			<title>PR.com Press Releases: NanoCellect News</title>
			<link>https://www.PR.com/</link>
			<width>68</width>
			<height>69</height>
			<description>PR.com provides press release distribution, and is a unique directory of businesses, products and services. Find full company profiles.</description>
		</image>
		<atom:link href="https://www.pr.com/rss/press-releases-2/441669.xml" rel="self" type="application/rss+xml" />
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/783902</guid>
			<title>NanoCellect Biomedical Begins Distribution to Europe</title>
			<pubDate>Wed, 01 May 2019 11:00:00 -0400</pubDate>
			<description>NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced an exclusive distribution agreement with Basel, Switzerland-based Bucher Biotec AG. The agreement covers sales in Switzerland of NanoCellect&#8217;s WOLF&#174;Cell Sorter, N1 Single-Cell Dispenser, consumables and software. Bucher represents U.S. and European manufacturers [PR.com]</description>
			<link>https://www.pr.com/press-release/783902</link>
			<dc:creator>NanoCellect</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/657193</guid>
			<title>NanoCellect Closes $1.75M Series A Financing Round to Begin Production of the WOLF Cell Sorter</title>
			<pubDate>Mon, 08 Feb 2016 06:42:07 -0500</pubDate>
			<description>NanoCellect Biomedical, a developer of affordable and accessible flow cytometry and cell sorting technology for life sciences, will begin production of their WOLF Cell Sorter. The Series A investment was led by Ken Hood of San Diego’s FusionX Ventures, an early-stage investment fund. [PR.com]</description>
			<link>https://www.pr.com/press-release/657193</link>
			<dc:creator>NanoCellect</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/635440</guid>
			<title>NanoCellect and UCSD Team Up on Single-Cell Sorting and Analysis</title>
			<pubDate>Wed, 02 Sep 2015 03:00:00 -0400</pubDate>
			<description>NanoCellect Biomedical, a developer of affordable and accessible flow cytometry and cell sorting technology for life science researchers, begins a collaboration with UCSD to develop single cell applications based on their WOLF Cell Sorter. The WOLF Cell Sorter enables easy-to-use cell sorting that avoids the biohazards and shear stress of traditional cell sorters. The WOLF eliminates sample contamination between runs and [PR.com]</description>
			<link>https://www.pr.com/press-release/635440</link>
			<dc:creator>NanoCellect</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/522628</guid>
			<title>Microfluidics Startup NanoCellect Adds Strategic Advisors and Nabs Another $700K from the NIH</title>
			<pubDate>Sat, 19 Oct 2013 03:00:00 -0400</pubDate>
			<description>NanoCellect, (previously called NanoSort) aims to facilitate breakthrough biomedical discoveries by making cell analysis and sorting technology more affordable and easier to use. Spunout from UCSD in late 2009, NanoCellect has now raised over $3.3M including a new $700K grant to continue developing microfluidic cell analysis technology. The team also recently expanded by adding top tier advisory board members with [PR.com]</description>
			<link>https://www.pr.com/press-release/522628</link>
			<dc:creator>NanoCellect</dc:creator>
		</item>
	</channel>
</rss>